Cohen Robert,Carr Suzette,Hagerty David,Peach Robert J.,Becker Jean-Claude
申请号：
SI200131067
公开号：
SI1935427T1
申请日:
2001.07.02
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
The present invention relates to compositions and methods for treating rheumatic disease by administering to a subject, soluble CTLA4 mutant molecules that block endogenous B7 molecules from binding their ligands.
